Sonoma Biotherapeutics, Inc. — Form D

Sonoma Biotherapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-11. The offering totals $265.0M, of which $265.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-08-11
• Form: D
• Accession: 0001877861-21-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $265.0M
• Amount sold: $265.0M
• Remaining: $7
• Investors: 40
• Date of first sale: 2021-07-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-409599

Issuer

• Name: Sonoma Biotherapeutics, Inc.
• CIK: 0001877861
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Incorporated: 2019
• Address: 400 E. JAMIE CT., SUITE 202, SOUTH SAN FRANCISCO, CA, 94080
• Phone: (415) 992-6245

Officers, directors & promoters (8)

More

• CIK 1877861 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search